Skip to content

Clinical trials

Recruiting Coronary Artery Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Status: Recruiting Country / region: China Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20121
20131
20151
20162
20171
20182
20191
20203
20225
202311
202419
202528
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting94

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Center for Cardiovascular Diseases12
Shanghai Zhongshan Hospital7
Nanjing First Hospital, Nanjing Medical University6
Ruijin Hospital6
Second Affiliated Hospital, Zhejiang University, School of Medicine5
Xijing Hospital5
Peking Union Medical College Hospital4
BrosMed Medical Co., Ltd3
Tianjin Chest Hospital3
Beijing Anzhen Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease94
Acute Coronary Syndrome6
Coronary Stenosis5
Inflammation5
Atherosclerosis4
Cardiovascular Diseases4
Coronary Disease4
Coronary Restenosis3
Diabetes Mellitus, Type 23
Disease Progression3

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.